Progress in the overall understanding of typhoid fever: implications for vaccine development
- 2 April 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Vaccines
- Vol. 19 (4), 367-382
- https://doi.org/10.1080/14760584.2020.1750375
Abstract
Introduction: Typhoid fever continues to have a substantial impact on human health, especially in Asia and sub-Saharan Africa. Access to safe water, and adequate sanitation and hygiene remain the cornerstone of prevention, but these are not widely available in many impoverished settings. The emergence of antibiotic resistance affects typhoid treatment and adds urgency to typhoid control efforts. Vaccines provide opportunities to prevent and control typhoid fever in endemic settings. Areas covered: Literature search was performed looking for evidence concerning the global burden of typhoid and strategies for prevention and treatment of typhoid fever. Cost of illness, available typhoid and paratyphoid vaccines and cost effectiveness were also reviewed. The objective was to provide a critical overview of typhoid fever, in order to assess the current understanding and potential future directions for typhoid treatment and control. Expert Opinion: Our understanding of typhoid burden and methods of prevention has grown over recent years. However, typhoid fever still has a significant impact on health in low and middle income countries. Introduction of typhoid conjugate vaccines to the immunization schedule is expected to make a major contribution to control of typhoid fever in endemic countries, although vaccination alone is unlikely to eliminate the disease.Keywords
Funding Information
- Bill & Melinda Gates Foundation (NA)
- NIHR Oxford Biomedical Research Centre (NA)
This publication has 121 references indexed in Scilit:
- Water, sanitation, hygiene and enteric infections in childrenArchives of Disease in Childhood, 2013
- Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in AfricaThe Lancet, 2012
- Live Oral Typhoid Vaccine Ty21a Induces Cross-Reactive Humoral Immune Responses against Salmonella enterica Serovar Paratyphi A andS. Paratyphi B in HumansClinical and Vaccine Immunology, 2012
- The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant VaccinesClinical and Vaccine Immunology, 2011
- Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD−S. Typhi-specific IgA and IgG B memory cells in humansClinical Immunology, 2011
- Immunology of gut mucosal vaccinesImmunological Reviews, 2010
- Neonatal and Infantile Immune Responses to Encapsulated Bacteria and Conjugate VaccinesJournal of Immunology Research, 2008
- Randomized Controlled Comparison of Ofloxacin, Azithromycin, and an Ofloxacin-Azithromycin Combination for Treatment of Multidrug-Resistant and Nalidixic Acid-Resistant Typhoid FeverAntimicrobial Agents and Chemotherapy, 2007
- Test for quinolone resistance in typhoid feverBMJ, 2006
- Current concepts in the diagnosis and treatment of typhoid feverBMJ, 2006